Syncona (LON:SYNC) Sets New 12-Month High – What’s Next?

Syncona (LON:SYNC) hit a new 52-week high during trading on Tuesday . The company traded as high as GBX 117 and last traded at GBX 115.41, with a volume of 10509 shares traded. The stock had previously closed at GBX 117.

Wall Street Analysts Forecast Growth

Separately, Peel Hunt reaffirmed a “buy” rating and set a GBX 189 target price on shares of Syncona in a report on Tuesday, August 4th. One research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of GBX 189.

Syncona Stock Performance

The firm’s 50 day moving average price is GBX 107.19 and its 200-day moving average price is GBX 98.84. The firm has a market capitalization of £701.93 million, a PE ratio of -79.59 and a beta of 0.36.

Insider Buying and Selling at Syncona

In other Syncona news, insider John Roche purchased 16,063 shares of Syncona stock in a transaction that occurred on Friday, June 19th. The stock was bought at an average price of GBX 100 per share, with a total value of £16,063. 0.75% of the stock is currently owned by corporate insiders.

Syncona Company Profile

Syncona’s purpose is to invest to extend and enhance human life. We do this by creating, building and scaling companies to deliver transformational treatments to patients in areas of high unmet need. We aim to build and maintain a diversified portfolio of 20-25 globally leading life science businesses, across development stage, modality and therapeutic area, for the benefit of all our stakeholders. We focus on developing treatments that deliver patient impact by working in close partnership with world-class academic founders and experienced management teams.